Prevtec microbia

Prevtec microbia

Canadian biotechnology company specialized in the development of vaccines and other technologies that help fight against bacterial diseases in food animals. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
$60m (Public information from Aug 2019)
Montreal Quebec (HQ)
  • Edit
DateInvestorsAmountRound

€3.0m

Early VC
N/A

$4.7m

Early VC

$2.5m

Early VC
N/A

$8.0m

Debt

$59.9m

Valuation: $60.0m

Acquisition
Total Funding$10.5m

Recent News about Prevtec microbia

Edit
More about Prevtec microbiainfo icon
Edit

Prevtec Microbia specializes in developing and commercializing innovative microbial solutions aimed at improving animal health and productivity. Operating in the animal health industry, the company primarily serves livestock producers and veterinary professionals. Prevtec Microbia's core product offerings include probiotics and other microbial-based products designed to enhance the gut health of animals, thereby improving their overall well-being and productivity. The company operates on a B2B (business-to-business) model, generating revenue through the sale of its microbial solutions to farms, veterinary clinics, and animal health distributors. By focusing on cutting-edge research and development, Prevtec Microbia aims to address key challenges in animal health, such as disease prevention and growth promotion, while reducing the need for antibiotics. The company is headquartered in Basel, Switzerland, and leverages a global network to distribute its products.

Keywords: microbial solutions, animal health, probiotics, livestock, veterinary, gut health, productivity, B2B, disease prevention, antibiotic reduction.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.